Kim H, Jusue-Torres I, Kondziolka D, Cornelia Lee P, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K (2017) Guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery. https://doi.org/10.1093/neuros/nyx091
Article PubMed PubMed Central Google Scholar
Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA (2008) Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 39(12):3222–3230. https://doi.org/10.1161/STROKEAHA.108.515544
Spiegler S, Rath M, Paperlein C, Felbor U (2018) Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol 9(2):60–69. https://doi.org/10.1159/000486292
Article CAS PubMed PubMed Central Google Scholar
Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL, Mabray MC, Vigil C, Tang AT, Kahn ML, Yonas H, Lawton MT, Kim H, Morrison L (2019) Familial cerebral cavernous malformations. Stroke 50(5):1294–1301. https://doi.org/10.1161/strokeaha.118.022314
Article PubMed PubMed Central Google Scholar
Snellings DA, Girard R, Lightle R, Srinath A, Romanos S, Li Y, Chen C, Ren AA, Kahn ML, Awad IA, Marchuk DA (2022) Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nature Cardiovasc Res 1:246–252. https://doi.org/10.1038/s44161-022-00035-7
Dammann P, Wrede K, Zhu Y, Matsushige T, Maderwald S, Umutlu L, Quick HH, Hehr U, Rath M, Ladd ME, Felbor U, Sure U (2017) Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI. J Neurosurg 126(2):570–577. https://doi.org/10.3171/2016.2.jns152322
Perrelli A, Retta SF (2021) Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of cerebral cavernous malformation disease. Free Radical Biol Med 172:403–417. https://doi.org/10.1016/j.freeradbiomed.2021.06.021
Kufs H (1928) Über die heredofamiläre Angiomatose des Gehirns und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Neurol Psychiatrie 113:651–686
Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23(2):189–193. https://doi.org/10.1038/13815
Article CAS PubMed Google Scholar
Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8(12):2325–2333
Article CAS PubMed Google Scholar
Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73(6):1459–1464. https://doi.org/10.1086/380314
Article CAS PubMed PubMed Central Google Scholar
Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Human Genetics 74(2):326–337. https://doi.org/10.1086/381718
Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E, Neurochirurgie SFD (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76(1):42–51. https://doi.org/10.1086/426952
Article CAS PubMed Google Scholar
Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E (2013) Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med 19(5):302–308. https://doi.org/10.1016/j.molmed.2013.02.004
Article CAS PubMed Google Scholar
Snellings DA, Hong CC, Ren AA, Lopez-Ramirez MA, Girard R, Srinath A, Marchuk DA, Ginsberg MH, Awad IA, Kahn ML (2021) Cerebral cavernous malformation: from mechanism to therapy. Circ Res 129(1):195–215. https://doi.org/10.1161/CIRCRESAHA.121.318174
Article CAS PubMed PubMed Central Google Scholar
Wetzel-Strong SE, Detter MR, Marchuk DA (2017) The pathobiology of vascular malformations: insights from human and model organism genetics. J Pathol 241(2):281–293. https://doi.org/10.1002/path.4844
Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, Arthur JS, Whitehead KJ, Awad IA, Li DY, Zheng X, Kahn ML (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 532(7597):122–126. https://doi.org/10.1038/nature17178
Article CAS PubMed PubMed Central Google Scholar
Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207(4):881–896. https://doi.org/10.1084/jem.20091258
Article CAS PubMed PubMed Central Google Scholar
Ressler AK, Snellings DA, Girard R, Gallione CJ, Lightle R, Allen AS, Awad IA, Marchuk DA (2023) Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in cerebral cavernous malformations. Nat Commun 14(1):7009. https://doi.org/10.1038/s41467-023-42908-w
Article CAS PubMed PubMed Central Google Scholar
Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18(5):919–930. https://doi.org/10.1093/hmg/ddn430
Article CAS PubMed Google Scholar
McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S, De Castro N, Berg MJ, Corcoran DL, Awad IA, Marchuk DA (2014) Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet 23(16):4357–4370. https://doi.org/10.1093/hmg/ddu153
Article CAS PubMed PubMed Central Google Scholar
Lanfranconi S, Scola E, Meessen J, Pallini R, Bertani GA, Al-Shahi Salman R, Dejana E, Latini R, Treat CCMI (2023) Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial. Lancet Neurol 22(1):35–44. https://doi.org/10.1016/S1474-4422(22)00409-4
Article CAS PubMed Google Scholar
Alfa R, Considine T, Virani S, Pfeiffer M, Donato A, Dickerson D, Shuster D, Ellis J, Rushton K, Wei H, Gibson C (2024) Clinical pharmacology and tolerability of REC-994, a redox-cycling nitroxide compound, in randomized phase 1 dose-finding studies. Pharmacol Res Perspect 12(3):e1200. https://doi.org/10.1002/prp2.1200
Article CAS PubMed PubMed Central Google Scholar
Morrison L, Gutierrez J, Ayata C, Lopez-Toledano M, Carrazana E, Awad I, Rabinowicz AL, Kim H (2024) Current and future treatment options for cerebral cavernous malformations. Stroke-Vasc Interv N 4(3):e001140. https://doi.org/10.1161/SVIN.123.001140
Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L, Fong ELS, Balachander GM, Chen Z, Soragni A, Huch M, Zeng YA, Wang Q, Yu H (2022) Organoids. Nat Rev Methods Prim. https://doi.org/10.1038/s43586-022-00174-y
Kim J, Koo BK, Knoblich JA (2020) Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 21(10):571–584. https://doi.org/10.1038/s41580-020-0259-3
Comments (0)